Medexus Pharmaceuticals Inc.
MDP.TOTSXHealthcare● Active
$3.95
+$0.04(+1.02%)
Market Cap$127586501
P/E Ratio—
52W High$4.17
52W Low$2.47
Medexus Pharmaceuticals Inc.（MDP.TO）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MDP.TO · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.00B | ($0.00B) | $0.00B | ($0.00B) | ($0.03B) |
| Depreciation & Amort. | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.01B | ($0.01B) | ($0.02B) | $0.01B | $0.00B |
| Net Cash from Operations | $0.02B | $0.02B | ($0.00B) | ($0.00B) | $0.01B |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.01B) | ($0.01B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.01B) | ($0.00B) | ($0.00B) | ($0.01B) | ($0.01B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.01B) | ($0.03B) | $0.01B | $0.00B | ($0.00B) |
| Net Cash from Financing | $0.00B | ($0.02B) | $0.01B | $0.00B | $0.02B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.02B | $0.02B | ($0.00B) | ($0.01B) | ($0.01B) |
| FCF Margin %(computed) | 19.67% | 16.32% | -1.67% | -11.60% | -7.18% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Medexus Pharmaceuticals Inc.
关于Medexus Pharmaceuticals Inc.（MDP.TO）现金流量表
Medexus Pharmaceuticals Inc. 2025财年经营活动现金流$0.02B，自由现金流$0.02B（FCF利润率19.67%），资本支出($0.00B)。
常见问题
MDP.TO · 4 问Medexus Pharmaceuticals Inc. 2025财年自由现金流$0.02B，同比up15.5%。
MDP.TO free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10